MGNX MACROGENICS INC revenue, earnings and financials

For the quarter ended June 30, 2026, MACROGENICS INC reported revenue of $32.8M (up 378.0% from a year earlier), net income of $19.5M and diluted EPS of $0.31; over the last four quarters revenue was $183M and net income $60.0M; for the fiscal year ended December 2025 revenue was $150M, down 0.3% on the year before.

MGNX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $150M, gross profit n/a, operating income −$72.8M, net income −$74.6K (margin 0.0%), EPS −$1.18
• Fiscal year ended Dec 2024: revenue $150M, gross profit n/a, operating income −$111M, net income −$67.0K (margin 0.0%), EPS −$1.07
• Fiscal year ended Dec 2023: revenue $58.7M, gross profit n/a, operating income −$168M, net income −$9.06K (margin 0.0%), EPS −$0.15
• Fiscal year ended Dec 2022: revenue $152M, gross profit n/a, operating income −$121M, net income −$120M (margin -78.8%), EPS −$1.95
• Fiscal year ended Dec 2021: revenue $77.4M, gross profit n/a, operating income −$203M, net income −$202M (margin -261.0%), EPS −$3.37

MGNX quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $32.8M (up 378.0% year over year), net income $19.5M, EPS $0.31
• Quarter ended Mar 31, 2026: revenue $20.8M (up 57.5% year over year), net income −$36.8M, EPS −$0.58
• Quarter ended Dec 31, 2025 (from the annual report): revenue $56.6M (up 192.5% year over year), net income $60.4M, EPS −$0.23
• Quarter ended Sep 30, 2025: revenue $72.8M (down 34.2% year over year), net income $16.8M, EPS $0.27
• Quarter ended Jun 30, 2025: revenue $6.87M (down 36.4% year over year), net income −$36.3M, EPS −$0.57
• Quarter ended Mar 31, 2025: revenue $13.2M (up 44.9% year over year), net income −$41.0M, EPS −$0.65
• Quarter ended Dec 31, 2024 (from the annual report): revenue $19.4M (up 80.5% year over year), net income $51.5M, EPS −$0.24
• Quarter ended Sep 30, 2024: revenue $111M (up 964.8% year over year), net income $56.3M, EPS $0.90
• Quarter ended Jun 30, 2024: revenue $10.8M (down 17.8% year over year), net income −$55.7M, EPS −$0.89
• Quarter ended Mar 31, 2024: revenue $9.10M (down 62.8% year over year), net income −$52.2M, EPS −$0.84
• Quarter ended Dec 31, 2023 (from the annual report): revenue $10.7M (down 85.3% year over year), net income −$37.0M, EPS −$0.74
• Quarter ended Sep 30, 2023: revenue $10.4M (down 75.1% year over year), net income $17.6M, EPS $0.28
• Quarter ended Jun 30, 2023: revenue $13.1M (down 49.5% year over year), net income $57.5M, EPS $0.92
• Quarter ended Mar 31, 2023: revenue $24.5M (up 120.7% year over year), net income −$38.0M, EPS −$0.61
• Quarter ended Dec 31, 2022 (from the annual report): revenue $73.1M (up 416.7% year over year), net income $12.8M, EPS $0.20
• Quarter ended Sep 30, 2022: revenue $41.7M (up 166.5% year over year), net income −$24.8M, EPS −$0.40
• Quarter ended Jun 30, 2022: revenue $26.0M (down 15.4% year over year), net income −$41.3M, EPS −$0.67
• Quarter ended Mar 31, 2022: revenue $11.1M (down 34.2% year over year), net income −$66.4M, EPS −$1.08
• Quarter ended Dec 31, 2021 (from the annual report): revenue $14.1M, net income −$58.0M, EPS −$0.95
• Quarter ended Sep 30, 2021: revenue $15.7M, net income −$52.9M, EPS −$0.86

MGNX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$81.0M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$68.4M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$78.2M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$87.0M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$144M, share buybacks n/a

MGNX balance sheet

• Jun 30, 2026: cash $114M, total assets $345M, total liabilities $303M, shareholders' equity $42.9M
• Mar 31, 2026: cash $66.5M, total assets $218M, total liabilities $197M, shareholders' equity $21.2M
• Dec 31, 2025: cash $57.2M, total assets $257M, total liabilities $201M, shareholders' equity $55.6M
• Sep 30, 2025: cash $80.1M, total assets $271M, total liabilities $204M, shareholders' equity $67.0M
• Jun 30, 2025: cash $131M, total assets $245M, total liabilities $199M, shareholders' equity $46.6M
• Mar 31, 2025: cash $146M, total assets $225M, total liabilities $145M, shareholders' equity $79.1M
• Dec 31, 2024: cash $183M, total assets $262M, total liabilities $146M, shareholders' equity $116M
• Sep 30, 2024: cash $180M, total assets $264M, total liabilities $144M, shareholders' equity $120M

What is MGNX's revenue?

MACROGENICS INC reported $183M of revenue over its last four quarters, through June 30, 2026.

Is MGNX profitable?

Yes. MACROGENICS INC earned $60.0M over the last four quarters.

What is MGNX's EPS?

Diluted earnings per share over the last four quarters were −$0.23; $0.31 in the latest quarter.

MGNX ownership and insider trades · All stocks